129 related articles for article (PubMed ID: 8739514)
1. Luteinizing hormone releasing hormone agonist for postpartum contraception.
Mayagoitia SB; Hernández-Morales C; Macías AM; Vega RR
Adv Contracept; 1996 Mar; 12(1):27-41. PubMed ID: 8739514
[TBL] [Abstract][Full Text] [Related]
2. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonist for postpartum contraception: biochemical, hormonal and endometrial effects.
Vega RR; Barraza-Vázquez A; Vega MG; Fernández-González EM; Mayagoitia SB
Adv Contracept; 1996 Mar; 12(1):15-25. PubMed ID: 8739513
[TBL] [Abstract][Full Text] [Related]
4. Risk of ovulation during lactation.
Gray RH; Campbell OM; Apelo R; Eslami SS; Zacur H; Ramos RM; Gehret JC; Labbok MH
Lancet; 1990 Jan; 335(8680):25-9. PubMed ID: 1967336
[TBL] [Abstract][Full Text] [Related]
5. The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year.
Landgren BM; Jonsson B; Cekan SZ
Contraception; 1995 Apr; 51(4):255-60. PubMed ID: 7796592
[TBL] [Abstract][Full Text] [Related]
6. Lactational infertility in family planning.
Short RV
Ann Med; 1993 Apr; 25(2):175-80. PubMed ID: 8489757
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
[TBL] [Abstract][Full Text] [Related]
8. Breast-feeding and postpartum ovulation.
Howie PW; Mcneilly AS
IPPF Med Bull; 1982 Apr; 16(2):1-3. PubMed ID: 12311528
[TBL] [Abstract][Full Text] [Related]
9. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
10. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
11. Ovarian sonographic findings during intermittent intranasal luteinizing hormone-releasing hormone agonist sequentially combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N; Bastide A
Fertil Steril; 1987 Jan; 47(1):60-6. PubMed ID: 2947818
[TBL] [Abstract][Full Text] [Related]
12. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
Coutinho EM; Athayde C; Dantas C; Hirsch C; Barbosa I
Contraception; 1999 Feb; 59(2):115-22. PubMed ID: 10361626
[TBL] [Abstract][Full Text] [Related]
13. GnRH analogues for contraception.
Fraser HM
Br Med Bull; 1993 Jan; 49(1):62-72. PubMed ID: 8324616
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
15. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
[TBL] [Abstract][Full Text] [Related]
16. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.
Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT
Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.
Short RV; Lewis PR; Renfree MB; Shaw G
Lancet; 1991 Mar; 337(8743):715-7. PubMed ID: 1672186
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
19. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
Bergquist C; Nillius SJ; Wide L
Fertil Steril; 1982 Aug; 38(2):190-3. PubMed ID: 6809500
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH.
Gudmundsson JA; Nillius SJ; Bergquist C
Contraception; 1984 Aug; 30(2):107-14. PubMed ID: 6238805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]